Review and evaluate the role of a psychiatric pharmacist on medication management in a Gender Health Program

被引:2
|
作者
Wartman, Carolanne [1 ,2 ]
Walroth, Todd A. [1 ,2 ]
Butterfield, David [1 ,2 ]
Anderson, Lindsey [1 ,2 ]
Peters, Michael [1 ]
Schmelz, Andrew [1 ,3 ]
Ott, Carol [1 ,2 ,4 ]
机构
[1] Eskenazi Hlth, Dept Pharm, Indianapolis, IN 46202 USA
[2] Purdue Univ, Coll Pharm, Dept Pharm Practice, W Lafayette, IN 47907 USA
[3] Butler Univ, Dept Pharm Practice, Coll Pharm, Indianapolis, IN 46208 USA
[4] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
关键词
mental health; pharmacists; psychiatry; transgender persons;
D O I
10.1002/jac5.1722
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction People who identify as transgender experience a significant amount of mental health concerns compared to the general population. Gender health programs offer the opportunity to provide comprehensive care for this highly stigmatized population, with the potential for psychiatric pharmacists to assist other providers and serve this need. This study aimed to evaluate the number and type of interventions made by a psychiatric pharmacist within a Gender Health Program. Methods A retrospective review of the electronic medical record was conducted analyzing mental health visits completed by psychiatric pharmacists within the Gender Health Program between May 1, 2020 and December 31, 2021. The primary outcome was number and type of interventions, defined as medication adjustments, laboratory monitoring, and completion of prior authorizations. Secondary outcomes included a description of medication regimens, number and type of patient education provided, and referrals to other healthcare professionals. Key subgroup analyses consisted of number of interventions based on gender identity, race identity, and insurance status. Results There were a total of 152 appointments among 93 patients. Sixty-one patients (66%) received at least one intervention [median (interquartile range, IQR) of 2 (2, 4)], which occurred across 81 pharmacist appointments (53%). Psychotropic medications were adjusted at 79 appointments (97%), with primarily medication initiations. Patient education was completed and documented at 102 appointments with a median (IQR) of 2 (1, 2) topics discussed per appointment. There was a statistically significant difference found between transmen and transwomen on number of interventions [31 (67%) vs 15 (45%), P = 0.048]. Conclusion The pharmacist in this study had the opportunity to bridge gaps in access to care to healthcare providers by initiating and managing medications, providing thorough education, and referring patients to further resources. This study affirms the accessibility and role of a psychiatric pharmacist on the interdisciplinary team caring for lesbian, gay, bisexual, transgender, queer or questioning, and more (LGBTQ+) patients.
引用
下载
收藏
页码:1278 / 1283
页数:6
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management
    Schultz, Bob G.
    Tilton, Jessica
    Jun, Julie
    Scott-Horton, Tiffany
    Quach, Danny
    Touchette, Daniel R.
    VALUE IN HEALTH, 2021, 24 (04) : 522 - 529
  • [32] IMPACT OF A PHARMACIST MEDICATION ADHERENCE CONSULTATION PROGRAM ON HEALTH CARE COSTS AND RISK OF HOSPITALIZATION
    Wade, R. L.
    Hill, J. W.
    Akinbosoye, O.
    Jiang, Z.
    Mu, Y.
    Sun, K.
    Karkare, S.
    Taitel, M. S.
    VALUE IN HEALTH, 2015, 18 (03) : A3 - A3
  • [33] Pharmacist role in chronic disease medication management during disaster response.
    Nair, Vidya
    Sellers, Courtney
    Arnold, Jenny
    Gardner, Matthew
    Loehr, Michael
    PHARMACOTHERAPY, 2016, 36 (07): : E106 - E107
  • [34] Pharmacist-led interventions for the management of medication misuse and abuse: A systematic review
    Baum, Lindsay
    Badejo, Grace
    Chaboyer, Kevin
    Leong, Christine
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (03) : 297 - 298
  • [35] Pharmacist interventions in medication adherence in patients with mental health disorders: a scoping review
    Syrnyk, Matthew
    Glass, Beverley
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2023, 31 (05) : 449 - 458
  • [36] Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model
    Timothy F. Chen
    Drugs & Aging, 2016, 33 : 199 - 204
  • [37] Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model
    Chen, Timothy F.
    DRUGS & AGING, 2016, 33 (03) : 199 - 204
  • [38] Pharmacist membership in a medical group's diabetes health management program
    Brooks, Amie D.
    Rihani, Rami S.
    Derus, Charles L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (06) : 617 - 621
  • [39] Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients
    Rashida Muhammad Umar
    Sule Apikoglu-Rabus
    Perran Fulden Yumuk
    International Journal of Clinical Pharmacy, 2020, 42 : 652 - 661
  • [40] Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients
    Umar, Rashida Muhammad
    Apikoglu-Rabus, Sule
    Yumuk, Perran Fulden
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (02) : 652 - 661